Some Common Medicinal Plants with Antidiabetic Activity, Known and Available in Europe (A Mini-Review)
Streszczenie
Diabetes is a metabolic disease that affected 9.3% of adults worldwide in 2019. Its co-
occurrence is suspected to increase mortality from COVID-19. The treatment of diabetes is mainly
based on the long-term use of pharmacological agents, often expensive and causing unpleasant side
effects. There is an alarming increase in the number of pharmaceuticals taken in Europe. The aim of
this paper is to concisely collect information concerning the few antidiabetic or hypoglycaemic raw
plant materials that are present in the consciousness of Europeans and relatively easily accessible
to them on the market and sometimes even grown on European plantations. The following raw
materials are discussed in this mini-review: Morus alba L., Cinnamomum zeylanicum J.Presl, Trigonella
foenum-graecum L., Phaseolus vulgaris L., Zingiber officinale Rosc., and Panax ginseng C.A.Meyer in
terms of scientifically tested antidiabetic activity and the presence of characteristic biologically active
compounds and their specific properties, including antioxidant properties. The characteristics of
these raw materials are based on in vitro as well as in vivo studies: on animals and in clinical studies.
In addition, for each plant, the possibility to use certain morphological elements in the light of EFSA legislation is given.
Kolekcje
- Artykuły naukowe UPP [92]
Z tą pozycją powiązane są następujące pliki licencyjne: